
Keywords: ALR2; aldose reductase; ALR1; aldehyde reductase; ARIs; aldose reductase inhibitors; AKR1B1; aldo-keto reductase family1 member1; AKR1B10; aldo-keto reductase family1 member10; Glc; glucose; Ep; epalrestat; Aldose reductase inhibition; Diabetic compli